Pharmaceutical Industry Today

RAC Beta Serine Market Key Players – Critical Outcome Technologies Inc, Merck & Co Inc and Novartis AG Analysis & Forecast 2017 to 2022

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “RAC Beta Serine - Pipeline Review, H2 2017”
Published 21 February 2018

RAC Beta Serine

Overview

RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are developed by Companies.

The latest report RAC Beta SerineThreonine Protein Kinase - Pipeline Review, H2 2017, outlays comprehensive information on the RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2478914-rac-beta-serine-threonine-protein-kinase-protein-kinase-akt-2-or

Top Companies mentioned

ArQule Inc

Bayer AG

Critical Outcome Technologies Inc

Merck & Co Inc

Novartis AG

RAC Beta Serine Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide RAC Beta Serine   - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for RAC Beta Serine  , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - RAC-beta serine/threonine-protein kinase is an enzyme encoded by the AKT2 gene. It plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. AKT2 is also specifically involved in skeletal muscle differentiation, one of its substrates in this process being ANKRD2. The molecules developed by companies in Phase II, Phase I and Preclinical stages are 6, 2 and 3 respectively.

RAC Beta Serine pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

RAC Beta Serine - Competitive Analysis

Key players are making innovative developments in RAC Beta Serine industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of RAC Beta Serine.

The pipeline guide reviews pipeline therapeutics for RAC Beta Serine by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in RAC Beta Serine therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates RAC Beta Serine therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for RAC Beta Serine.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2478914-rac-beta-serine-threonine-protein-kinase-protein-kinase-akt-2-or

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Other Industry News

Ready to start publishing

Sign Up today!